Menno J. Van Nimwegen

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Neutralizing the IL-12/IL-23 p40 subunit prevents immune checkpoint blockade toxicity without compromising antitumor efficacy.

Neutralizing the IL-12/IL-23 p40 subunit prevents immune checkpoint blockade toxicity without compromising antitumor efficacy.

Journal: Cancer immunology research

Published: February 09, 2026

Common γ-chain cytokines induce an epigenomically plastic precursor-like KIT+ ILC2 state linked to immune disease susceptibility.

Common γ-chain cytokines induce an epigenomically plastic precursor-like KIT+ ILC2 state linked to immune disease susceptibility.

Journal: The Journal of allergy and clinical immunology

Published: December 15, 2025

Evidence for altered immune-structural cell crosstalk in cystic fibrosis revealed by single cell transcriptomics.

Evidence for altered immune-structural cell crosstalk in cystic fibrosis revealed by single cell transcriptomics.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: July 29, 2024

Aberrant characteristics of peripheral blood innate lymphoid cells in COPD, independent of smoking history.

Aberrant characteristics of peripheral blood innate lymphoid cells in COPD, independent of smoking history.

Journal: ERJ open research

Published: September 07, 2023

PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance.

PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance.

Journal: Science immunology

Published: May 19, 2023

Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity.

Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity.

Journal: International journal of molecular sciences

Published: May 05, 2022

Type-2 CD8+ T-cell formation relies on interleukin-33 and is linked to asthma exacerbations.

Type-2 CD8+ T-cell formation relies on interleukin-33 and is linked to asthma exacerbations.

Journal: Nature communications

Published: January 14, 2022

Low-Dose JAK3 Inhibition Improves Antitumor T-Cell Immunity and Immunotherapy Efficacy.

Low-Dose JAK3 Inhibition Improves Antitumor T-Cell Immunity and Immunotherapy Efficacy.

Journal: Molecular cancer therapeutics

Published: November 22, 2021

Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: A double-blind placebo-controlled trial.

Bacterial lysate add-on therapy to reduce exacerbations in severe asthma: A double-blind placebo-controlled trial.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: April 28, 2021

Involvement of Dendritic Cells and Th17 Cells in Induced Tertiary Lymphoid Structures in a Chronic Beryllium Disease Mouse Model.

Involvement of Dendritic Cells and Th17 Cells in Induced Tertiary Lymphoid Structures in a Chronic Beryllium Disease Mouse Model.

Journal: Mediators of inflammation

Published: August 21, 2020

Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases.

Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases.

Journal: Science immunology

Published: June 16, 2020

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model.

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model.

Journal: Journal for immunotherapy of cancer

Published: June 09, 2020

Showing 1-12 of 41

Last Updated: 09/26/2026